Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - CUBIST PHARMACEUTICALS INC | a10-5813_110q.htm |
| EX-10.2 - EX-10.2 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex10d2.htm |
| EX-32.2 - EX-32.2 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex32d2.htm |
| EX-31.2 - EX-31.2 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex31d2.htm |
| EX-32.1 - EX-32.1 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex32d1.htm |
| EX-10.1 - EX-10.1 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex10d1.htm |
| EX-31.1 - EX-31.1 - CUBIST PHARMACEUTICALS INC | a10-5813_1ex31d1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT VALUATION FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333,162764, 333-162763, 333-155352, 333-148455, 333-148454, 333-136937, 333-118065, 333-106388, 333-101908, 333-99739, 333-65385, 333-65383, 333-60168, 333-60152, 333-54140, 333-49522, 333-32178, 333-25707, 333-124210, 333-126225 and 333-132248) of Cubist Pharmaceuticals, Inc. of our report dated as of March 31, 2010, relating to the valuation of financial securities which appears in this Form 10-Q.
|
/s/Houlihan Smith & Company Inc. |
|
|
Houlihan Smith & Company Inc. |
|
|
Chicago, Illinois |
|
|
April 29, 2010 |
|